JOINT-STOCK COMPANY "BIOKAD" suspended work on creation of a vaccine against Koronavirus BCD-250

The Russian biotechnological JOINT-STOCK COMPANY "BIOKAD" suspended work on creation of own vaccine of BCD-250 against Koronavirus. director general reported companies about it TASS Dmitry Sivokoz. According to him, experts concentrated attention on work on other directions, including providing patients with available innovative therapy. "To Russian Federation a large number of the registered vaccines, and they showed the efficiency. Besides, WHO declared that the pandemic is almost complete. Incidence indicators also speak for themselves", – general director told companies...